Adverse effects and safety of antidepressants and psychedelics for depression in cancer: a systematic review of randomized controlled trials (2025)
- Authors:
- USP affiliated authors: HALLAK, JAIME EDUARDO CECILIO - FMRP ; SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; MAEKAWA, RENAN MASSANOBU - FMRP ; GUERRA, LORENA TERENE LOPES - FMRP
- Unidade: FMRP
- DOI: 10.3390/psychoactives4010006
- Subjects: DEPRESSÃO; ANTIDEPRESSIVOS; NEOPLASIAS; REVISÃO SISTEMÁTICA
- Keywords: Adverse effects; Cancer patients; Safety; Tolerability; Antidepressants; Psychedelics
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Psychoactives
- ISSN: 2813-1851
- Volume/Número/Paginação/Ano: v. 4, art. 6, [20] p, 2025
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
MAEKAWA, Renan Massanobu et al. Adverse effects and safety of antidepressants and psychedelics for depression in cancer: a systematic review of randomized controlled trials. Psychoactives, v. 4, 2025Tradução . . Disponível em: https://doi.org/10.3390/psychoactives4010006. Acesso em: 16 abr. 2026. -
APA
Maekawa, R. M., Guerra, L. T. L., Bouso, J. C., Hallak, J. E. C., & Santos, R. G. dos. (2025). Adverse effects and safety of antidepressants and psychedelics for depression in cancer: a systematic review of randomized controlled trials. Psychoactives, 4. doi:10.3390/psychoactives4010006 -
NLM
Maekawa RM, Guerra LTL, Bouso JC, Hallak JEC, Santos RG dos. Adverse effects and safety of antidepressants and psychedelics for depression in cancer: a systematic review of randomized controlled trials [Internet]. Psychoactives. 2025 ; 4[citado 2026 abr. 16 ] Available from: https://doi.org/10.3390/psychoactives4010006 -
Vancouver
Maekawa RM, Guerra LTL, Bouso JC, Hallak JEC, Santos RG dos. Adverse effects and safety of antidepressants and psychedelics for depression in cancer: a systematic review of randomized controlled trials [Internet]. Psychoactives. 2025 ; 4[citado 2026 abr. 16 ] Available from: https://doi.org/10.3390/psychoactives4010006 - Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant
- Psychedelic medicines in major depression: progress and future challenges
- Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy [Editorial]
- Hallucinations and hallucinogens: psychopathology or wisdom?
- Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences
- Acute psychological adverse reactions in first-time ritual ayahuasca users: a prospective case series
- Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects
- Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: evidence and mechanisms of action
- Effects of ayahuasca on mental health and quality of life in naïve users: a longitudinal and cross-sectional study combination
- Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
